These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8885152)

  • 41. Anti-D prophylaxis in 1997: the Edinburgh Consensus Statement.
    James D
    Arch Dis Child Fetal Neonatal Ed; 1998 May; 78(3):F161-3. PubMed ID: 9713023
    [No Abstract]   [Full Text] [Related]  

  • 42. [Epidemiology of anti-D allo-immunization during pregnancy].
    Branger B; Winer N
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S87-1S92. PubMed ID: 16495833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prevention of maternal isoimmunization to RhD antigen].
    Baptista González HA; Rosenfeld Mann F
    Salud Publica Mex; 2004; 46(3):194-5; author reply 196-7. PubMed ID: 15368858
    [No Abstract]   [Full Text] [Related]  

  • 44. Rh-immunoglobulin: Rh prophylaxis.
    Bowman J
    Best Pract Res Clin Haematol; 2006; 19(1):27-34. PubMed ID: 16377539
    [No Abstract]   [Full Text] [Related]  

  • 45. Some observations on D antigen expression of D-positive and 'weak D-positive' red cells as assessed by flow cytometry.
    Nelson M; Barrow LA; Popp H; Gibson J
    Vox Sang; 1995; 69(2):152-4. PubMed ID: 8585204
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect on primary Rh immunization of delayed administration of anti-Rh.
    Samson D; Mollison PL
    Immunology; 1975 Feb; 28(2):349-57. PubMed ID: 804437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful prevention of post-transfusion Rh alloimmunization by intravenous Rho (D) immune globulin (WinRho SD).
    Anderson B; Shad AT; Gootenberg JE; Sandler SG
    Am J Hematol; 1999 Mar; 60(3):245-7. PubMed ID: 10072121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rh immunization facilitated by passively-administered anti-Rh?
    Contreras M; Mollison PL
    Br J Haematol; 1983 Jan; 53(1):153-9. PubMed ID: 6293530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparison of the efficacy of different methods for the prevention of anti-D allo-immunization during pregnancy: targeted strategy limited to risk situations or associated with systematic prevention in the 3rd trimester].
    Parant O
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S93-1S103. PubMed ID: 16495834
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of immunization to D+ red blood cells with red blood cell exchange and intravenous Rh immune globulin.
    Nester TA; Rumsey DM; Howell CC; Gilligan DM; Drachman JG; Maier RV; Kyles DM; Matthews DC; Pendergrass TW
    Transfusion; 2004 Dec; 44(12):1720-3. PubMed ID: 15584986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Failure of passively administered anti-Rh to prevent secondary Rh responses.
    de Silva M; Contreras M; Mollison PL
    Vox Sang; 1985; 48(3):178-80. PubMed ID: 2984846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resolution by erythrocytapheresis of the exposure of an Rh-negative person to Rh-positive cells: an alternative treatment.
    Werch J; Todd C
    Transfusion; 1993 Jun; 33(6):530-2. PubMed ID: 8390730
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Important variations of maternal anti-Rhesus (D) antibody level during two consecutive pregnancies without antigenic stimulus.
    Moncharmont P; Juron-Dupraz F; Rigal D; Meyer F
    Acta Haematol; 1990; 83(2):105-6. PubMed ID: 2106193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monitoring and treatment of anti-D in pregnancy.
    Bettelheim D; Panzer S; Reesink HW; Csapo B; Pessoa C; Guerra F; Wendel S; Calda P; Sprogøe U; Dziegiel M; Aitokallio-Tallberg A; Koskinen S; Kuosmanen M; Legler TJ; Stein W; Villa S; Villa MA; Trespidi L; Acaia B; Vandenbussche FP; Brand A; de Haas M; Kanhai HH; Gounder D; Flanagan P; Donegan R; Parry E; Sefonte C; Skulstad SM; Hervig T; Flesland Ø; Zupańska B; Uhrynowska M; Lapaire O; Zhong XY; Holzgreve W
    Vox Sang; 2010 Aug; 99(2):177-92. PubMed ID: 20331536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A dose of 100 IU intravenous anti-D gammaglobulin is effective for the prevention of RhD immunisation after RhD-incompatible single donor platelet transfusion.
    Zeiler T; Wittmann G; Zingsem J; Weisbach V; Zimmermann R; Eckstein R
    Vox Sang; 1994; 66(3):243. PubMed ID: 8036796
    [No Abstract]   [Full Text] [Related]  

  • 56. Efficacy and safety of monoclonal anti-D immunoglobulin in comparison with polyclonal anti-D immunoglobulin in prevention of rho isoimmunization.
    Chauhan AR; Bhattacharyya MS; Turakhia N; Daftary GV
    J Assoc Physicians India; 2002 Oct; 50():1341-2. PubMed ID: 12568238
    [No Abstract]   [Full Text] [Related]  

  • 57. Intravenous anti-D gammaglobulin for the prevention of rhesus isoimmunization caused by platelet transfusions in patients with malignant diseases.
    Heim MU; Böck M; Kolb HJ; Schleuning M; Mempel W
    Vox Sang; 1992; 62(3):165-8. PubMed ID: 1319096
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of an antigen on the inner surface of Rh negative erythrocytes which binds anti-D IgG.
    Evans JP; Brown PJ; Sinor LT; Tilzer LL; Beck M; Plapp FV
    Mol Immunol; 1983 May; 20(5):529-36. PubMed ID: 6308430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral administration of erythrocyte membrane antigen does not suppress anti-Rh(D) antibody responses in humans.
    Barnes RM; Duguid JK; Roberts FM; Risk JM; Johnson PM; Finn R; Hardy J; Napier JA; Clarke CA
    Clin Exp Immunol; 1987 Jan; 67(1):220-6. PubMed ID: 3113783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antenatal prophylaxis with anti-D immunoglobulin.
    BMJ; 1989 Oct; 299(6704):919-20. PubMed ID: 2555002
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.